The Uromigos

The Uromigos podcast, hosted by Tom Powles, professor of genitourinary oncology at Barts Cancer Centre, and Brian Rini, Ingram Professor of Medicine at Vanderbilt-Ingram Cancer Center, aims to broadcast the latest developments in GU cancer. Each episode features fascinating discussions with leading experts from around the world and dives into the data and clinical news relevant to the care of GU oncology patients. In their “Legends of GU Oncology” series, the podcasting duo focus on the founders of the field.

Articles by The Uromigos

The UromigosThe Uromigos | October 28, 2024
Returning guests Bertrand Tombal and Silke Gillessen join the podcast to dive into data from the 2024 APCCC.
Listen Now
The UromigosThe Uromigos | October 23, 2024
Special guest Bertrand Tombal of Manchester Cancer Research Centre focuses on the historic and current data of AR inhibition
The UromigosThe Uromigos | October 16, 2024
Christopher Cutie from J and J joins the show to discuss the SUNRISE bladder program.
The UromigosUromigos Live 2024 | October 15, 2024
Listen to the podcast format of the kidney cancer panel on IO after IO therapy from Uromigos Live 2024.
The UromigosThe Uromigos | September 30, 2024
Drs. Maite Bourlon, Elena Castro and Cristina Suarez cover the UC topics discussed on day 1 of Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 30, 2024
Listen to the podcast format of the peri-operative therapy in bladder cancer panel from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the kidney cancer panel on TKI vs Ipi/Nivo vs IO/TKI from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on radioligand data in prostate cancer from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on T cell directed therapy in prostate cancer from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on on emerging ADC data in bladder cancer from Uromigos Live 2024.
The UromigosThe Uromigos | September 24, 2024
Tom and Brian finish discussing bladder and kidney cancer highlights from ESMO 2024.
The UromigosThe Uromigos | September 23, 2024
Silke joins us to discuss ESMO 2024 highlights, then the birds start singing....
The UromigosThe Uromigos | September 19, 2024
Fresh off the Presidential session address, Tom discusses his data with Petros commenting.
The UromigosThe Uromigos | September 16, 2024
Uromigos Japan with Yuji, Hiroshi and Nobu is formed and discuss Hiroshi's ESMO data.
The UromigosThe Uromigos | September 17, 2024
Arun Azad describes this randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel vs. docetaxel in mHSPC.
The UromigosThe Uromigos | September 17, 2024
Matt Galsky describes his ESMO 2024 abstract of disitimab vedotin + pembrolizumab in bladder cancer.
The UromigosThe Uromigos | September 17, 2024
Silke Gillessen joins us to discuss her Presidential session from ESMO 2024.
The UromigosThe Uromigos | October 14, 2024
Lothar Bergmann describes this investigator-initiated trial of Ipi/Nivo vs SOC in Non-clear Cell RCC.
The UromigosThe Uromigos | September 23, 2024
Brad McGregor joins Brian and Tom to discuss a new HIF inhibitor, NKT2152, and preliminary data in RCC.
The UromigosThe Uromigos | September 23, 2024
Katy Beckermann discusses the TiNivo-2 study presented at ESMO 2024.